Mesenchymal stem cells maintain long-term in vitro stemness during explant culture

Tissue Engineering - Part C: Methods

Volumn 19, Issue 12, 2013, Pages 937-948

  Otte, Anna ^a   Bucan, Vesna ^a   Reimers, Kerstin ^a   Hass, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELLS; TISSUE CULTURE; TISSUE ENGINEERING;

FLOW-CYTOMETRIC ANALYSIS; MESENCHYMAL STEM CELL; MICROENVIRONMENTS; PROLIFERATION RATE; REGENERATIVE MEDICINE; SURFACE MARKERS; TELOMERASE ACTIVITY; TISSUE REPLACEMENT;

TISSUE;

5' NUCLEOTIDASE; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; TELOMERASE; THY 1 ANTIGEN;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHONDROGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXPLANT; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; PRIORITY JOURNAL; SENESCENCE; STEM CELL CULTURE; STEMNESS; UMBILICAL CORD;

ANTIGENS, CD; CELL CULTURE TECHNIQUES; CELL CYCLE; CELLS, CULTURED; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MESENCHYMAL STROMAL CELLS; TIME FACTORS; UMBILICAL CORD;

EID: 84888387997     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2013.0007     Document Type: Article

References (50)

1. Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P.N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., Buhring, H.J., Giacobino, J.P., Lazzari, L., Huard, J., and Peault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
2. Caplan, A.I., and Correa, D. The MSC: an injury drugstore. Cell Stem Cell 9, 11, 2011.
3. Wolbank, S., van Griensven, M., Grillari-Voglauer, R., and Peterbauer-Scherb, A. Alternative sources of adult stem cells: human amniotic membrane. Adv Biochem Eng Biotechnol 123, 1, 2010.
4. Hilfiker, A., Kasper, C., Hass, R., and Haverich, A. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbecks Arch Surg 396, 489, 2011.
5. Hass, R., Kasper, C., Bohm, S., and Jacobs, R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9, 12, 2011.
6. Can, A., and Karahuseyinoglu, S. Concise review: human umbilical cord stroma with regard to the source of fetusderived stem cells. Stem Cells 25, 2886, 2007.
7. Kita, K., Gauglitz, G.G., Phan, T.T., Herndon, D.N., and Jeschke, M.G. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 19, 491, 2009.
8. Covas, D.T., Siufi, J.L., Silva, A.R., and Orellana, M.D. Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 36, 1179, 2003.
9. Panepucci, R.A., Siufi, J.L., Silva, W.A., Jr., Proto-Siquiera, R., Neder, L., Orellana, M., Rocha, V., Covas, D.T., and Zago, M.A. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22, 1263, 2004.
10. Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M.M., and Davies, J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23, 220, 2005.
11. Mitchell, K.E., Weiss, M.L., Mitchell, B.M., Martin, P., Davis, D., Morales, L., Helwig, B., Beerenstrauch, M., Abou-Easa, K., Hildreth, T., Troyer, D., and Medicetty, S. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21, 50, 2003.
12. Weiss, M.L., Medicetty, S., Bledsoe, A.R., Rachakatla, R.S., Choi, M., Merchav, S., Luo, Y., Rao, M.S., Velagaleti, G., and Troyer, D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24, 781, 2006.
13. La Rocca, G., Anzalone, R., Corrao, S., Magno, F., Loria, T., Lo Iacono, M., Di Stefano, A., Giannuzzi, P., Marasa, L., Cappello, F., Zummo, G., and Farina, F. Isolation and characterization of Oct-4 + /HLA-G + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131, 267, 2009.
14. Majore, I., Moretti, P., Hass, R., and Kasper, C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal 7, 6, 2009.
15. Hass, R., and Otte, A. Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal 10, 26, 2012.
16. Chen, T.S., Lai, R.C., Lee, M.M., Choo, A.B., Lee, C.N., and Lim, S.K. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38, 215, 2010.
17. Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., Shang, X., Zhang, Z.G., and Chopp, M. Exosomemediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30, 1556, 2012.
18. Zhu, W., Huang, L., Li, Y., Zhang, X., Gu, J., Yan, Y., Xu, X., Wang, M., Qian, H., and Xu, W. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 315, 28, 2012.
19. D'Souza, N., Burns, J.S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, S., Horwitz, E.M., Paolucci, P., Conte, P., and Dominici, M. MSC and tumors: homing, differentiation, and secretion influence therapeutic potential. Adv Biochem Eng Biotechnol, 2012. [Epub ahead of print]; doi: 10.1007/10-2012-150.
20. Bertram, C., and Hass, R. Cellular responses to reactive oxygen species-induced DNA damage and aging. Biol Chem 389, 211, 2008.
21. Lavrentieva, A., Majore, I., Kasper, C., and Hass, R. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun Signal 8, 18, 2010.
22. Zhang, H.C., Liu, X.B., Huang, S., Bi, X.Y., Wang, H.X., Xie, L.X., Wang, Y.Q., Cao, X.F., Lv, J., Xiao, F.J., Yang, Y., and Guo, Z.K. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev 21, 3289, 2012.
23. Hass, R., Meinhardt, G., Hadam, M., and Bartels, H. Characterization of human TUR leukemia cells: continued cell cycle progression in the presence of phorbol ester is associated with resistance to apoptosis. Eur J Cell Biol 65, 408, 1994.
24. Yegorov, Y.E., Akimov, S.S., Hass, R., Zelenin, A.V., and Prudovsky, I.A. Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp Cell Res 243, 207, 1998.
25. Otte, A., Gohring, G., Steinemann, D., Schlegelberger, B., Groos, S., Langer, F., Kreipe, H.H., Schambach, A., Neumann, T., Hillemanns, P., Park-Simon, T.W., and Hass, R. A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type. Int J Oncol 41, 765, 2012.
26. Cao, C., and Dong, Y. Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19, 642, 2005.
27. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
28. Schop, D., Janssen, F.W., van Rijn, L.D., Fernandes, H., Bloem, R.M., de Bruijn, J.D., and van Dijkhuizen-Radersma, R. Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng 15, 1877, 2009.
29. Shake, J.G., Gruber, P.J., Baumgartner, W.A., Senechal, G., Meyers, J., Redmond, J.M., Pittenger, M.F., and Martin, B.J. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73, 1919, 2002.
30. Wakitani, S., Goto, T., Pineda, S.J., Young, R.G., Mansour, J.M., Caplan, A.I., and Goldberg, V.M. Mesenchymal cellbased repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76, 579, 1994.
31. Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L., and Hofmann, T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99, 8932, 2002.
32. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344, 385, 2001.
33. Lee, J.K., Jin, H.K., Endo, S., Schuchman, E.H., Carter, J.E., and Bae, J.S. Intracerebral transplantation of bone marrowderived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28, 329, 2010.
34. Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I., and Lazarus, H.M. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18, 307, 2000.
35. Horwitz, E.M., and Dominici, M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy 10, 771, 2008.
36. Majumdar, M.K., Thiede, M.A., Haynesworth, S.E., Bruder, S.P., and Gerson, S.L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9, 841, 2000.
37. Caplan, A.I., and Dennis, J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98, 1076, 2006.
38. Meirelles Lda, S., Fontes, A.M., Covas, D.T., and Caplan, A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20, 419, 2009.
39. Hatlapatka, T., Moretti, P., Lavrentieva, A., Hass, R., Marquardt, N., Jacobs, R., and Kasper, C. Optimization of culture conditions for the expansion of umbilical cordderived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng Part C Methods 17, 485, 2011.
40. Majore, I., Moretti, P., Stahl, F., Hass, R., and Kasper, C. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev 7, 17, 2011.
41. Friedl, P., and Alexander, S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992, 2011.
42. Ungefroren, H., Sebens, S., Seidl, D., Lehnert, H., and Hass, R. Interaction of tumor cells with the microenvironment. Cell Commun Signal 9, 18, 2011.
43. Hass, R., and Bertram, C. Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies. J Exp Clin Cancer Res 28, 127, 2009.
44. Bertram, C., and Hass, R. Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures. Mech Ageing Dev 130, 657, 2009.
45. Chaturvedi, S., and Hass, R. Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. Mech Ageing Dev 132, 213, 2011.
46. Lennon, D.P., Schluchter, M.D., and Caplan, A.I. The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells. Stem Cells Transl Med 1, 279, 2012.
47. Kulterer, B., Friedl, G., Jandrositz, A., Sanchez-Cabo, F., Prokesch, A., Paar, C., Scheideler, M., Windhager, R., Preisegger, K.H., and Trajanoski, Z. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8, 70, 2007.
48. Gieseke, F., Bohringer, J., Bussolari, R., Dominici, M., Handgretinger, R., and Muller, I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116, 3770, 2010.
49. Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A.M., and Silberstein, L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24, 1030, 2006.
50. Gregory, L.A., Ricart, R.A., Patel, S.A., Lim, P.K., and Rameshwar, P. microRNAs, Gap junctional intercellular communication and mesenchymal stem cells in breast cancer metastasis. Curr Cancer Ther Rev 7, 176, 2011.